Guideline Therapeutics and COVID-19: living guideline
Rapid characterization of spike variants via mammalian cell surface display | bioRxiv
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
Rapid characterization of spike variants via mammalian cell surface display
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 - eBioMedicine
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain | bioRxiv
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ) - Banerjee - 2021 - Journal of Neurochemistry - Wiley Online Library
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
新型コロナウイルス感染症に関する 国内外の研究開発動向について
Guideline Therapeutics and COVID-19: living guideline
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use | ACS Nano
